Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Knapp

Showing results (21-30 of 540) with videos related to

Pageof 54
Sort By:
Current Opinion in Chemical Biology|April 24, 2022
BET bromodomain inhibitorsMartin P Schwalm, Stefan Knapp
Expert Reviews in Molecular Medicine|September 22, 2011
Bromodomains as therapeutic targetsSusanne Muller, Panagis Filippakopoulos, Stefan Knapp
Structure (London, England : 1993)|November 8, 2018
A Pseudo-Kinase Double ActFranziska Preuß, Sebastian Mathea, Stefan Knapp
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Annotation of the Effect of Chemogenomic Compounds on Cell Health Using High-Content Microscopy in Live-Cell ModeAmelie Tjaden, Stefan Knapp, Susanne Müller
Current Opinion in Structural Biology|November 21, 2009
SH2 domains: modulators of nonreceptor tyrosine kinase activityPanagis Filippakopoulos, Susanne Müller, Stefan Knapp
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
High-Throughput Purification of Protein Kinases from Escherichia coli and Insect CellsSebastian Mathea, Eidarus Salah, Stefan Knapp
Scientific Reports|August 12, 2020
Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1Xiaomin Ni, Stefan Knapp, Apirat Chaikuad
Acta Crystallographica. Section F, Structural Biology Communications|February 16, 2025
LOPAC library screening identifies suramin as a TRIM21 binder with a unique binding mode revealed by crystal structureYeojin Kim, Stefan Knapp, Andreas Krämer
Cancer Metastasis Reviews|January 23, 2009
Targeting group II PAKs in cancer and metastasisJeyanthy Eswaran, Meera Soundararajan, Stefan Knapp
Structure (London, England : 1993)|April 5, 2018
A Pseudo-Kinase Double ActFranziska Preuß, Sebastian Mathea, Stefan Knapp
Pageof 54

Showing results (21-30 of 540) with videos related to

Sort By:
Pageof 54
Current Opinion in Chemical Biology|April 24, 2022
BET bromodomain inhibitorsMartin P Schwalm, Stefan Knapp
Expert Reviews in Molecular Medicine|September 22, 2011
Bromodomains as therapeutic targetsSusanne Muller, Panagis Filippakopoulos, Stefan Knapp
Structure (London, England : 1993)|November 8, 2018
A Pseudo-Kinase Double ActFranziska Preuß, Sebastian Mathea, Stefan Knapp
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Annotation of the Effect of Chemogenomic Compounds on Cell Health Using High-Content Microscopy in Live-Cell ModeAmelie Tjaden, Stefan Knapp, Susanne Müller
Current Opinion in Structural Biology|November 21, 2009
SH2 domains: modulators of nonreceptor tyrosine kinase activityPanagis Filippakopoulos, Susanne Müller, Stefan Knapp
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
High-Throughput Purification of Protein Kinases from Escherichia coli and Insect CellsSebastian Mathea, Eidarus Salah, Stefan Knapp
Scientific Reports|August 12, 2020
Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1Xiaomin Ni, Stefan Knapp, Apirat Chaikuad
Acta Crystallographica. Section F, Structural Biology Communications|February 16, 2025
LOPAC library screening identifies suramin as a TRIM21 binder with a unique binding mode revealed by crystal structureYeojin Kim, Stefan Knapp, Andreas Krämer
Cancer Metastasis Reviews|January 23, 2009
Targeting group II PAKs in cancer and metastasisJeyanthy Eswaran, Meera Soundararajan, Stefan Knapp
Structure (London, England : 1993)|April 5, 2018
A Pseudo-Kinase Double ActFranziska Preuß, Sebastian Mathea, Stefan Knapp
Pageof 54